Reuters: Alcon ends macular degeneration drug program

[natalie]

Alcon ends macular degeneration drug program
      

LOS ANGELES (Reuters) - Alcon Inc said on Friday that it has ended development of anecortave acetate as a treatment for lowering the risk of a sight-threatening eye disease known as age-related macular degeneration.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login